Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
Pharmacopsychiatry. 2022 Mar;55(2):e1.
doi: 10.1055/a-1737-1527.
Epub 2022 Jan 20.
1 Mental Health Research Center, Eastern State Hospital, Lexington, KY, USA.
2 Department of Psychiatry, University of Kentucky, Lexington, KY, USA.
3 Psychiatry and Neurosciences Research Group (CTS-549), Institute of Neurosciences, University of Granada, Granada, Spain.
4 Biomedical Research Centre in Mental Health Net (CIBERSAM), Santiago Apostol Hospital, University of the Basque Country, Vitoria, Spain.
5 Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zürich, Zürich, Switzerland.
6 The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, New York, USA.
7 Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
8 Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway.
9 Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
10 Department of Psychiatry, Tampere University Hospital, Tampere, Finland.
11 Department of Psychiatry, Satasairaala, Finland.
12 National Institute of Mental Health, Klecany, Czech Republic.
13 Department of Psychiatry, Charles University, Third Faculty of Medicine, Prague, Czech Republic.
14 Clinical Pharmacology Unit and Pharmacy Department, Vilardebó Hospital, Administración de Servicios de Salud, Montevideo, Uruguay.
15 Clinical Pharmacology Unit and Outpatient Clinic, Vilardebó Hospital, Administración de Servicios de Salud, Montevideo, Uruguay.
16 Universidad de Oviedo. CIBERSAM. INEUROPA. ISPA-FIMBA, Oviedo, Spain.
17 Hospital Valle del Nalón, Langreo, Spain.
18 Hospital Universitario Central de Asturias, Oviedo, Spain.
19 Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
20 Laboratory of Clinical Psychopharmacology, Beijing Anding Hospital, Capital Medical University, Beijing, China.
21 The National Clinical Research Centre for Mental Disorders & Beijing Key Lab of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
22 Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing, China.
23 Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
24 Substance Abuse Treatment Program, Atlanta VA Medical Center, Decatur, Georgia, USA.
25 Department of Psychiatry, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
26 Department of Psychiatry, School of Medicine, Taipei Medical University, Taipei, Taiwan.
27 Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
28 Department of Psychiatry and Brain Disease Research Center, China Medical University Hospital, Taichung, Taiwan.
29 Department of Psychology, College of Medical and Health Sciences, Asia University, Taichung, Taiwan.
30 Department of Neuropsychiatry, Nowon Eulji Medical Center, Eulji University, School of Medicine, Seoul, Korea.
31 Department of Psychiatry, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
32 Department of Psychiatry, Christian Medical College, Vellore, India.
33 Institute of Mental Health, Jubilee Campus, University of Nottingham, Triumph Road, Nottingham, United Kingdom.
34 Instituto Nacional de Neurología y Neurocirugía, México City, México.
35 Facultad de Química, Universidad Nacional Autónoma de México (UNAM), México City, México.
36 Department of Physiology, Los Andes University Medical School, Mérida, Venezuela.
37 Department of Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
38 Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
39 Mental Health Centre Glostrup, Copenhagen University Hospital, Copenhagen, Denmark.
40 Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Team Pharmacoepidemiology, UMR 1219, F-33000 Bordeaux, France.
41 Department of Physical Medicine and Pharmacology, School of Medicine, Universidad de La Laguna, Canary Islands, Spain.
42 Hospital Universitario de Canarias, Tenerife, Spain.
43 Department of Internal Medicine, Dermatology and Psychiatry, School of Medicine, and Instituto Universitario de Neurociencia (IUNE), University of La Laguna, Canary Islands, Spain.
44 Dutch Clozapine Collaboration Group, Castricum, The Netherlands.
45 FACT-team in Heerhugowaard, Department of Severe Mental Illness, Mental Health Services North-Holland North, The Netherlands.
46 Mental Health Team Alkmaar, Mental Health Services Noord-Holland-Noord, Alkmaar, The Netherlands.
47 Department of Psychiatry, Hacettepe University Faculty of Medicine, Ankara, Turkey.
48 Addictions Division, Centre for Addiction and Mental Health, Toronto, Canada.
49 Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
50 Eastern State Hospital, Lexington, Kentucky, USA.
51 Hazelwood Center, Louisville, Kentucky, USA.
52 Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hempstead, New York, USA.
53 School of Medicine, Keele University, Staffordshire, and Midlands Partnership NHS Foundation Trust, Staffordshire, United Kingdom.
54 Department of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia.
55 Department of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA.
56 Department of Psychiatry and Psychotherapy, University Medical Center of Mainz, Germany.
57 Grupo de Investigación en Psiquiatría GIPSI, Departamento de Psiquiatría, Facultad de Medicina, Universidad de Antioquia, Medellin, Colombia.
58 Programa Trastornos del Ánimo, Hospital Universitario San Vicente Fundación, Medellín, Colombia.
59 Department of Pharmacy Practice, University of Montana, Missoula, USA.
60 Institute of Neuropsychiatry and Addictions (INAD), Parc de Salut Mar, Barcelona, Spain.
61 Department of Psychiatry, Autonomous University of Barcelona, Spain.
62 Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neurosciences, Lausanne University Hospital and University of Lausanne, Switzerland.
63 Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Switzerland.
64 School of Pharmaceutical Sciences, University of Geneva, Switzerland.
65 Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Switzerland.
66 Department of Psychiatry, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
67 Center for Drug Sciences, Faculty of Pharmacy, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
68 Te Korowai Whāriki Central Regional Forensic Service, Capital and Coast District Health Board, Wellington, New Zealand.
69 Department of Psychological Medicine, University of Otago, Wellington, New Zealand.
70 Departments of Medical Genetics, Psychiatry, Physiology & Pharmacology, and Community Health Sciences University of Calgary, Alberta, Canada.
71 Faculty of Medicine, University of Montreal, Montreal, Canada.
72 Department of Pharmacy, Hôpital du Sacré-Cœur de Montréal, Montreal, Canada.
73 East London NHS Foundation Trust, London, United Kingdom.
74 Honorary Clinical Senior Lecturer, Barts and the London School of Medicine, Queen Mary University of London, United Kingdom.
75 Department of Psychiatry, School of Medicine, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, Maryland, USA.
76 Department of Psychiatry, Asahi General Hospital, Chiba, Japan.
77 National Institute of Mental Health, Neurology and Neurosurgery, Budapest, Hungary.
78 Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
79 Secretaría de Salud Mental y Adicciones, Ministerio de Salud de la Provincia de Jujuy, San Salvador de Jujuy, Argentina.
80 Instituto Vilapriño, Center for Studies, Assistance and Research in Neurosciences, Mendoza, Argentina.
81 Department of Psychiatry, LSK Faculty of Medicine, The University of Hong Kong, Hong Kong SAR.
82 State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong SAR.
83 College of Pharmacy, QU Health, Qatar University, Doha, Qatar.
84 Department of Psychiatry, Hamad Medical Corporation, Doha, Qatar.
85 NHS, Department of Mental Health, "G. Mazzini" Hospital, Teramo, Italy.
86 Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
87 British Columbia Mental Health and Substance Use Research Institute, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
88 Federal Neuropsychiatric Hospital Yaba, Lagos, Nigeria.
89 Department of Clinical Pharmacology, Astrakhan State Medical University, Astrakhan, Russian Federation.
90 Department of Psychiatry and Clinical Psychology, Northern State Medical University, Arkhangelsk, Russia.
91 3rd Department of Psychiatry, Division of Neurosciences, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece.
92 Department of Psychiatry, Medical University of Gdańsk, Gdańsk, Poland.
93 Department of Psychiatry, Queens University, Kingston, Canada.
94 Psychiatry Department, Centro Hospitalar Universitário de S. João, Porto, Portugal.
95 Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
96 Sigmund Freud University, Vienna, Austria.
97 Department of Neurosciences, Jerez University Hospital, Andalusian Health Service, University of Cadiz, Jerez, Spain.
98 Department of Psychiatry, School of Medicine, University Hospital Virgen del Rocio-IBIS, Sevilla, Spain.
99 Spanish Network for Research in Mental Health (CIBERSAM), Sevilla, Spain.
100 Department of Psychiatry and Mental Health, University of Cape Town, Valkenberg Hospital, Western Cape, Cape Town, South Africa.
101 Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
102 Hospital Central de Maputo, Maputo, Mozambique.
103 Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
104 Department of Psychiatry, Okayama Psychiatric Medical Center, Okayama, Japan.
105 Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
106 Department of Psychiatry, School of Medicine, University of Zagreb, Zagreb, Croatia.
107 Department for Psychiatry and Psychological Medicine, University Hospital Center Zagreb, Croatia.
108 Department of Psychiatry, University Medical Centre Maribor, Maribor, Slovenia.
109 University of Kragujevac, Faculty of Medical Sciences, Department of Psychiatry, Kragujevac, Serbia.
110 Group of Resistant Schizophrenia (GER), Schizophrenia Program (Proesq), Federal University of Sao Paulo, SP, Brazil.
111 Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Sao Paulo, Brazil.
112 Department and Institute of Psychiatry and Mental Health, Oporto Faculty of Medicine, Oporto, Portugal.
113 Casa de Salidedo Som Jesus (Psychiatric Hospital), Oporto, Portugal.
114 INUBE Biosanitary Research Institute of Extremadura. Extremadura University Hospital and Medical School, Badajoz, Spain.
115 Spanish Network for Research in Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
116 Cambridge Psychosis Centre, Cambrigeshire and Peterborough NHS Foundation Trust & Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.
117 Metro South Addiction and Mental Health Service, Brisbane, Australia.
118 Queensland Centre for Mental Health Research and School of Clinical Medicine, University of Queensland, Brisbane, Australia.
119 Research Unit, Geha Mental Health Center and Molecular Psychiatry Laboratory, Felsenstein Medical Research Center, Tel Aviv, Israel.
120 Department of Psychiatry Sackler Faculty of Medicine and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
121 Psychiatry "A" Department, Hedi Chaker University Hospital, Sfax, Tunisia.
122 Faculty of Medicine, University of Sfax, Sfax, Tunisia.
123 Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
124 Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
125 School of Medicine, Virginia Commonwealth University, Richmond, VA, USA.
126 Semel Institute for Neuroscience at UCLA, Los Angeles, CA, USA.
127 VA Desert Pacific Mental Illness Research, Education, and Clinical Center, Los Angeles, CA, USA.
128 New York Medical College, Department of Psychiatry and Behavioral Sciences, Valhalla, NY, USA.
129 Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
130 Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany.